Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess insulin action on peripheral glucose utilization and nonesterified fatty acid (NEFA) suppression as a predictor of coronary artery calcification (CAC) in patients with type 1 diabetes and nondiabetic controls. RESEARCH DESIGN AND METHODS: Insulin action was measured by a three-stage hyperinsulinemic-euglycemic clamp (4, 8, and 40 mU/m2/min) in 87 subjects from the Coronary Artery Calcification in Type 1 Diabetes cohort (40 diabetic, 47 nondiabetic; mean age 45 ± 8 years; 55% female). RESULTS: Peripheral glucose utilization was lower in subjects with type 1 diabetes compared with nondiabetic controls: glucose infusion rate (mg/kg FFM/min) = 6.19 ± 0.72 vs. 12.71 ± 0.66, mean ± SE, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and final clamp glucose and insulin. Insulin-induced NEFA suppression was also lower in type 1 diabetic compared with nondiabetic subjects: NEFA levels (μM) during 8 mU/m2/min insulin infusion = 370 ± 27 vs. 185 ± 25, P < 0.0001, after adjustment for age, sex, BMI, fasting glucose, and time point insulin. Lower glucose utilization and higher NEFA levels, correlated with CAC volume (r = −0.42, P < 0.0001 and r = 0.41, P < 0.0001, respectively) and predicted the presence of CAC (odds ratio [OR] = 0.45, 95% CI = 0.22–0.93, P = 0.03; OR = 2.4, 95% CI = 1.08–5.32, P = 0.032, respectively). Insulin resistance did not correlate with GHb or continuous glucose monitoring parameters. CONCLUSIONS: Type 1 diabetic patients are insulin resistant compared with nondiabetic subjects, and the degree of resistance is not related to current glycemic control. Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Excess adiposity was associated with inadequate glycemic control in patients with T1D in the T1D Exchange study cohort.34”
From Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786 · cited 1×
“Calcium volume scores (CVS) were calculated using the volumetric method, which is based on isotropic interpolation, as previously described (40,41).”
MethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“5 hours using the method of DeFronzo et al (39).”
MethodInfluentialIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“Insulin resistance has been strongly implicated as a cardiovascular risk factor in the general population(17-25).”
Background(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Self-citationKrolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654 · cited 2×
“9mmol/L), (3) Hyperglycemia, percentage of glucose values >180mg/dl (10mmol/L), and (4)Glycemic variability within days, overall standard deviation (SDT), the standard deviation of all glucose values.”
Background
Cited by
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
“More recently, a subgroup of the CACTI study underwent euglycemic clamps, and results showed that insulin resistance in T1DM patients compared with nondiabetic subjects was not related to their current level of glycemic control and yet predicted the extent of CAC.(157) by gest on O cber 4, 2017 http://ciajournals.”
ResultSelf-citationde Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 433
Self-citationInsulin resistance is a cardiovascular risk factor in humans
Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.023 · Cited by 313
Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review
Bjornstad, P., & Eckel, R. H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1101-6 · Cited by 243
Self-citationInsulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
Cleland, S. J., Fisher, B. M., Colhoun, H. M., Sattar, N., & Petrie, J. R. (2013) · Diabetologia · doi:10.1007/s00125-013-2904-2 · Cited by 238
“CAC Coronary artery calcification CVD Cardiovascular disease EDC Epidemiology of Diabetes Complications EDIC Epidemiology of Diabetes Interventions and Complications eGDR Estimated glucose disposal rate EHI Estimated hepatic insulin FAS Fatty acid synthase HDL-C HDL-cholesterol HL Hepatic lipase IDF International Diab…”
BackgroundInfluentialEstimated glucose disposal rate predicts mortality in adults with type 1 diabetes
Nyström, T., Holzmann, M. J., Eliasson, B., Svensson, A., & Sartipy, U. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13110 · Cited by 213
“This is further supported by the CACTI study in which insulin resistance, measured by the euglycemic hyperinsulinemic clamp, predicted the extent of coronary artery calcification, without any association with glycemic control[30].”
ResultDiabetes and beta cell function: from mechanisms to evaluation and clinical implications
Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203
Obesity in people living with type 1 diabetes
Van der Schueren, B., Ellis, D., Faradji, R. N., Al-Ozairi, E., Rosen, J., & Mathieu, C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00246-1 · Cited by 185
Libman, I. M., Miller, K. M., DiMeglio, L. A., Bethin, K. E., Katz, M. L., Shah, A., Simmons, J. H., Haller, M. J., Raman, S., Tamborlane, W. V., et al. (2015) · JAMA · doi:10.1001/jama.2015.16174 · Cited by 181
Insulin resistance in type 1 diabetes mellitus
Kaul, K., Apostolopoulou, M., & Roden, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.002 · Cited by 176
“Epidemiological studies in humans suggest that high iatrogenic hyperinsulinemia may contribute to insulin resistance in T1D and subsequently to associated complications [28,29].”
BackgroundBjornstad, P., Schäfer, M., Truong, U., Cree-Green, M., Pyle, L., Baumgartner, A., Garcia Reyes, Y., Maniatis, A., Nayak, S., Wadwa, R. P., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035525 · Cited by 143
Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications
Stabley, J. N., & Towler, D. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.306258 · Cited by 156
MiR-133a Modulates Osteogenic Differentiation of Vascular Smooth Muscle Cells
Liao, X., Zhang, Z., Yuan, K., Liu, Y., Feng, X., Cui, R.-R., Hu, Y., Yuan, Z., Gu, L., Li, S., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2236 · Cited by 144
Donga, E., Dekkers, O. M., Corssmit, E. P. M., & Romijn, J. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0911 · Cited by 121
Double diabetes: a distinct high-risk group?
Kietsiriroje, N., Pearson, S., Campbell, M., Ariëns, R. A. S., & Ajjan, R. A. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13848 · Cited by 123
“Healthy people with a family history of T2D exhibit a greater degree of insulin resistance and are prone to having higher BMI and body fat composition, even prior to the development of β-cell failure.15 A similar mechanism may be operating in DD, but not necessarily in the same order; insulin resistance may develop la…”
InfluentialSimmons, J. H., Chen, V., Miller, K. M., McGill, J. B., Bergenstal, R. M., Goland, R. S., Harlan, D. M., Largay, J. F., Massaro, E. M., Beck, R. W., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2643 · Cited by 120
“Although it is not possible to establish a causal relationship, exercise improves insulin sensitivity (12), as does lowering BMI (13).”
BackgroundInfluentialEicosanoids, β-cell function, and diabetes
Luo, P., & Wang, M.-H. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.06.001 · Cited by 131
Matrix Gla Protein Species and Risk of Cardiovascular Events in Type 2 Diabetic Patients
Dalmeijer, G. W., van der Schouw, Y. T., Magdeleyns, E. J. P., Vermeer, C., Verschuren, W. M. M., Boer, J. M. A., & Beulens, J. W. J. (2013) · Diabetes Care · doi:10.2337/dc13-0065 · Cited by 114
Bjornstad, P., Cherney, D. Z., Snell-Bergeon, J. K., Pyle, L., Rewers, M., Johnson, R. J., & Maahs, D. M. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv121 · Cited by 111
Self-citationFeatures of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell-Bergeon, J. K., Eckel, R. H., Perreault, L., & Rewers, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3172 · Cited by 107
“ported for the entire CACTI substudy (5).”
BackgroundSelf-citationColom, C., Rull, A., Sánchez‐Quesada, J. L., & Pérez, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081798 · Cited by 118
Why should people with type 1 diabetes exercise regularly?
Codella, R., Terruzzi, I., & Luzi, L. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0978-x · Cited by 120
Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
Cree-Green, M., Bergman, B. C., Cengiz, E., Fox, L. A., Hannon, T. S., Miller, K., Nathan, B., Pyle, L., Kahn, D., Tansey, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00129 · Cited by 101
Self-citationGarg, S. K., Moser, E. G., Bode, B. W., Klaff, L. J., Hiatt, W. R., Beatson, C. R., & Snell‐Bergeon, J. K. (2012) · Endocrine Practice · doi:10.4158/ep12100.or · Cited by 101
Self-citationNon-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus
Frandsen, C. S., Dejgaard, T. F., & Madsbad, S. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00039-5 · Cited by 101
A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
Priya, G., & Kalra, S. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0333-9 · Cited by 106
“Similarly, insulin resistance was a more significant determinant of coronary artery calcifications than hyperglycemia in the Coronary Artery Calcification in Type 1 Diabetes study [22].”
Bjornstad, P., Donaghue, K. C., & Maahs, D. M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30035-4 · Cited by 109
Self-citationCree-Green, M., Newcomer, B. R., Brown, M. S., Baumgartner, A. D., Bergman, B., Drew, B., Regensteiner, J. G., Pyle, L., Reusch, J. E. B., & Nadeau, K. J. (2015) · Diabetes · doi:10.2337/db14-0765 · Cited by 94
Self-citationInsulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Brugnara, L., Vinaixa, M., Murillo, S., Samino, S., Rodriguez, M. A., Beltran, A., Lerín, C., Davison, G. W., Correig, X., & Novials, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040600 · Cited by 98
Cardiovascular risk in double diabetes mellitus—when two worlds collide
Cleland, S. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.47 · Cited by 92
Specht, B. J., Wadwa, R. P., Snell-Bergeon, J. K., Nadeau, K. J., Bishop, F. K., & Maahs, D. M. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.07.036 · Cited by 78
“9%) (3) with T1D as compared with age, sex, pubertal stage, habitual level of physical activity, and BMI similar non-DM controls, despite lower HbA1c than pre-DCCT studies.”
BackgroundResultSelf-citationAdiponectin Dysregulation and Insulin Resistance in Type 1 Diabetes
Pereira, R. I., Snell-Bergeon, J. K., Erickson, C., Schauer, I. E., Bergman, B. C., Rewers, M., & Maahs, D. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2542 · Cited by 76
Self-citationThe Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes
Gregory, J. M., Cherrington, A. D., & Moore, D. J. (2020) · Diabetes · doi:10.2337/dbi19-0026 · Cited by 76
“, BMI, waist circumference, triglyceridemia) inversely correlated with insulin sensitivity among type 1 diabetes participants as expected, this relationship was effectively “left-shifted” for the type 1 diabetes participants compared with the control participants (13).”
BackgroundMethodDuca, L. M., Maahs, D. M., Schauer, I. E., Bergman, B. C., Nadeau, K. J., Bjornstad, P., Rewers, M., & Snell‐Bergeon, J. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3272 · Cited by 80
“5 Systolic BP, mm Hg 118 12 113 9 118 9 110 10 DBP, mm Hg 75 7 73 7 82 10 73 7 Hypertension, % [n] 65 [12] 29 [5] 22 [4] 13 [3] Steady-state glucose concentration, mg/dL 4.”
Self-citationExenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes
Sarkar, G., Alattar, M., Brown, R. J., Quon, M. J., Harlan, D. M., & Rother, K. I. (2014) · Diabetes Care · doi:10.2337/dc13-1473 · Cited by 74
Linn, W., Persson, M., Rathsman, B., Ludvigsson, J., Lind, M., Andersson, M., & Nyström, T. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01791-x · Cited by 73
Mäkinen, V., Tynkkynen, T., Soininen, P., Peltola, T., Kangas, A. J., Forsblom, C. M., Thorn, L. M., Kaski, K. K., Laatikainen, R., Ala‐Korpela, M., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr201036j · Cited by 76
Bjornstad, P., Snell‐Bergeon, J. K., Rewers, M., Jalal, D. I., Chonchol, M. B., Johnson, R. J., & Maahs, D. M. (2013) · Diabetes Care · doi:10.2337/dc13-0631 · Cited by 72
Self-citationObese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers
Patel, S. S., Truong, U., King, M., Ferland, A., Moreau, K. L., Dorosz, J., Hokanson, J. E., Wang, H., Kinney, G. L., Maahs, D. M., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x16682107 · Cited by 65
Self-citationPrevention of Cardiovascular Disease in Type 1 Diabetes
Manrique‐Acevedo, C., Hirsch, I. B., & Eckel, R. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2311526 · Cited by 79
Self-citationGrote, C. W., Morris, J. K., Ryals, J. M., Geiger, P. C., & Wright, D. E. (2011) · Experimental Diabetes Research · doi:10.1155/2011/212571 · Cited by 66
“demonstrated that type 1 patients are insulin resistant compared to nondiabetic subjects and that the degree of insulin resistance correlated with cardiovascular disease risk [56].”
BackgroundCardiovascular Disease Risk in Young People with Type 1 Diabetes
Snell‐Bergeon, J. K., & Nadeau, K. J. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9363-x · Cited by 84
“IR appears predominant in the pathophysiology of CVD in type 2 diabetes (T2D) and has recently emerged as a consistent finding among contemporary youth and adults with T1D [37, 38].”
Self-citationMetabolic Syndrome and Cardiometabolic Risk Factors
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 68
Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications
Coleman, S. K., Rebalka, I. A., D'Souza, D. M., & Hawke, T. J. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i17.1323 · Cited by 72
Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next Steps
on behalf of the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON), Driscoll, K. A., Corbin, K. D., Maahs, D. M., Pratley, R., Bishop, F. K., Kahkoska, A., Hood, K. K., & Mayer-Davis, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0892-1 · Cited by 66
Self-citationInsulin sensitivity and complications in type 1 diabetes: New insights
Bjornstad, P., Snell-Bergeon, J. K., Nadeau, K. J., & Maahs, D. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.8 · Cited by 76
Gregory, J. M., Smith, T. J., Slaughter, J. C., Mason, H. R., Hughey, C. C., Smith, M. S., Kandasamy, B., Greeley, S. A. W., Philipson, L. H., Naylor, R. N., et al. (2019) · Diabetes · doi:10.2337/db19-0324 · Cited by 63
Scott, S. N., Cocks, M. S., Andrews, R. C., Narendran, P., Purewal, T. S., Cuthbertson, D. J., Wagenmakers, A. J. M., & Shepherd, S. O. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01309 · Cited by 71
Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance
Cree-Green, M., Stuppy, J. J., Thurston, J., Bergman, B. C., Coe, G. V., Baumgartner, A. D., Bacon, S., Scherzinger, A., Pyle, L., & Nadeau, K. J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00433 · Cited by 61
Self-citationIs Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
Laakso, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0684-4 · Cited by 73
Linear parameter-varying model to design control laws for an artificial pancreas
Colmegna, P. H., Sánchez‐Peña, R., & Gondhalekar, R. (2017) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2017.09.021 · Cited by 63
Vascular Calcification in Diabetes: Mechanisms and Implications
Snell‐Bergeon, J. K., Budoff, M. J., & Hokanson, J. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0379-7 · Cited by 56
Self-citationRathsman, B., Rosfors, S., Sjöholm, Å., & Nyström, T. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-145 · Cited by 54
Shah, V. N., Sippl, R., Joshee, P., Pyle, L., Kohrt, W. M., Schauer, I. E., & Snell‐Bergeon, J. K. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4353-0 · Cited by 54
“(a measure of insulin sensitivity) as described previously [21].”
BackgroundMethodSelf-citationBjornstad, P., Maahs, D. M., Duca, L. M., Pyle, L., Rewers, M., Johnson, R. J., & Snell‐Bergeon, J. K. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.02.011 · Cited by 54
“…in conventional risk factors (e.g. hypertension, glycemic control and dyslipidemia) during the past two decades, vascular complications continue to be a major concern for health providers taking care of patients with T1D (Orchard, Secrest, Miller, & Costacou, 2010; Snell-Bergeon et al., 2003).”
BackgroundSelf-citationA Review of the Effect of Diet on Cardiovascular Calcification
Nicoll, R., Howard, J. M., & Henein, M. Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048861 · Cited by 56
“Although there are no studies considering dietary intake of sugars, diabetes mellitus, metabolic syndrome, insulin resistance and high blood glucose, HbA1C and triglycerides are known risk factors for the presence of aortic [32], carotid [33] and coronary artery calcification [34,35] and may also correlate with the ao…”
BackgroundRAGE activation in macrophages and development of experimental diabetic polyneuropathy
Osonoi, S., Mizukami, H., Takeuchi, Y., Sugawa, H., Ogasawara, S., Takaku, S., Sasaki, T., Kudoh, K., Ito, K., Sango, K., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160555 · Cited by 56
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell-Bergeon, J. K., Clement, T. W., Eckel, R. H., Perreault, L., & Rewers, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2892 · Cited by 51
“diabetes, is the finding that adults and children with type 1 diabetes exhibit whole-body insulin resistance compared with their euglycemic peers (1, 5, 7, 10, 11, 27, 28).”
BackgroundMethodSelf-citationNutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
March, C. A., BECKER, D. J., & Libman, I. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.622901 · Cited by 52
Challenges in Diagnosing Type 1 Diabetes in Different Populations
Rewers, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.2.90 · Cited by 49
“Most T1aD patients are insulin resistant compared to BMI-agematched non-diabetic controls [42].”
BackgroundSelf-citationChosich, J., Bradford, A. P., Allshouse, A. A., Reusch, J. E. B., Santoro, N. F., & Schauer, I. E. (2017) · Obesity · doi:10.1002/oby.21754 · Cited by 46
“As shown in Figure 3, both sexes exhibited a significant decrease in their glucose infusion rate during the euglycemic clamp with lipid infusion, indicating development of acute insulin resistance (23, 27).”
BackgroundMethodSelf-citationInsulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study
SHAH, A. S., Black, S., Wadwa, R. P., Schmiege, S. J., Fino, N. F., Talton, J. W., D’Agostino, R., Hamman, R. F., Urbina, E. M., Dolan, L. M., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.02.004 · Cited by 47
“insulin sensitivity was associated with coronary artery calcification (Schauer et al., 2011), a surrogate marker of coronary artery disease predictive of future CVD outcomes.”
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Snaith, J. R., Holmes-Walker, D. J., & Greenfield, J. R. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.11.007 · Cited by 45
Donga, E., van Dijk, M., Hoogma, R. P. L. M., Corssmit, E. P. M., & Romijn, J. A. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2343 · Cited by 42
The interplay of autoimmunity and insulin resistance in type 1 diabetes.
Nokoff, N., Rewers, M. J., & Cree‐Green, M. (2012) · PubMed · Cited by 51
Self-citationGregory, J. M., Kraft, G., Scott, M. F., Neal, D. W., Farmer, B., Smith, M. S., Hastings, J. R., Allen, E. J., Donahue, E. P., Rivera, N., et al. (2015) · Diabetes · doi:10.2337/db15-0071 · Cited by 44
Coronary Artery Calcification in Obese Youth: What Are the Phenotypic and Metabolic Determinants?
Bacha, F. F., Edmundowicz, D., Sutton-Tyrell, K., Lee, S., Tfayli, H. M., & Arslanian, S. A. (2014) · Diabetes Care · doi:10.2337/dc14-0193 · Cited by 43
Karamanakos, G., Kokkinos, A. D., Dalamaga, Μ., & Liatis, S. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00477-x · Cited by 49
Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes
Bacha, F. F., & Bartz, S. K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12337 · Cited by 46
“even in those under good glycemic control (23, 26).”
BackgroundRising incidence and challenges of childhood diabetes. A mini review.
Cizza, G., Brown, R. J., & Rother, K. I. (2012) · PubMed · doi:10.3275/8411 · Cited by 47
Canas, J. A., ROSS, J. L., Taboada, M., Sikes, K., Damaso, L. C., Hossain, J., Caulfield, M. P., Gidding, S. S., & Mauras, N. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12245 · Cited by 42
Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes
Snell-Bergeon, J. K., Kaur, G., Renner, D., Akturk, H. K., Beatson, C., & Garg, S. K. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0328 · Cited by 40
Self-citationFendler, W. M., Rizzo, M., Borowiec, M., Małachowska, B., Antosik, K., Szadkowska, A., Banach, M., Urbańska-Kosińska, M., Szopa, M., Malecki, M. T., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0567-1 · Cited by 40
“We are aware that calcification of coronary arteries was already shown to be frequent in patients with type 1 diabetes, although studies that focus on the subject generally cover patients with worse metabolic control and long-lasting diabetes [30, 31].”
BackgroundLiu, Y., Chen, C., Chen, Z., Peng, Y., Lin, X., & Xu, L. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3334 · Cited by 36
Wake, A. D. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.161 · Cited by 36
Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort
Millstein, R., Pyle, L. L., Bergman, B. C., Eckel, R. H., Maahs, D. M., Rewers, M., Schauer, I. E., & Snell‐Bergeon, J. K. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.01.002 · Cited by 36
“[6] Inclusion criteria included HbA1c ≤ 9.”
BackgroundSelf-citationGroener, J. B., Valkanou, A., Κender, Ζ., Pfeiffenberger, J., Kihm, L., Fleming, T. H., Nawroth, P. P., & Kopf, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222771 · Cited by 40
“The method for calculation of insulin sensitivity has been described before in a high-ranking publication in patients with diabetes mellitus type 1 [16], although at a blood glucose level of 90 mg/dl.”
MethodEpidemiological Research Advances in Vascular Calcification in Diabetes
Yao, H., Sun, Z., Zang, G., Zhang, L., Hou, L., Shao, C., & Wang, Z. (2021) · Journal of Diabetes Research · doi:10.1155/2021/4461311 · Cited by 38
Glycemic Targets in Pregnancies Affected by Diabetes: Historical Perspective and Future Directions
Hernandez, T. L. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0565-2 · Cited by 39
Myostatin inhibition therapy for insulin-deficient type 1 diabetes
Coleman, S. K., Rebalka, I. A., D’Souza, D. M., Deodhare, N., Desjardins, E. M., & Hawke, T. J. (2016) · Scientific Reports · doi:10.1038/srep32495 · Cited by 31
van der Hoogt, M., van Dyk, J. C., Dolman, R. C., & Pieters, M. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.10.002 · Cited by 33
Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes
Bjornstad, P., Snell‐Bergeon, J. K., McFann, K. K., Wadwa, R. P., Rewers, M., Rivard, C. J., Jalal, D. I., Chonchol, M. B., Johnson, R. J., & Maahs, D. M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.12.007 · Cited by 35
“Insulin sensitivity was calculated by Insulin Sensitivity Index (ISI) model derived from CACTI clamp studies (23).”
MethodSelf-citationLipid management for cardiovascular risk reduction in type 1 diabetes
Tell, S., Nadeau, K. J., & Eckel, R. H. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000551 · Cited by 30
Self-citationCardiovascular Disease in Diabetes
Py, Z. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-3512-6 · Cited by 30
Importance of the route of insulin delivery to its control of glucose metabolism
Edgerton, D. S., Moore, M. C., Gregory, J. M., Kraft, G., & Cherrington, A. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00628.2020 · Cited by 31
Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions
Khadilkar, A. V., Oza, C. M., & Mondkar, S. (2023) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514231206730 · Cited by 34
Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats
Mabuza, L. P., Gamede, M. W., Maikoo, S., Booysen, I. N., Ngubane, P. S., & Khathi, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s183811 · Cited by 31
“During PD, hypertension may be present at the onset of the disease.(28,29) The sympathetic nervous system overactivity exacerbates elevated blood pressure.”
McCulloch, M. A., Mauras, N., Canas, J. A., Hossain, J., Sikes, K., Damaso, L. C., Redheuil, A. B., ROSS, J. L., & Gidding, S. S. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12241 · Cited by 28
“Low ISS is associated with coronary artery calcifications (25), a surrogate marker for coronary artery disease predictive of future cardiovascular disease outcomes.”
BackgroundComparison of indirect markers of insulin resistance in adult patients with Double Diabetes
Ferreira‐Hermosillo, A., Ibarra‐Salce, R., Rodríguez-Malacara, J., & Molina-Ayala, M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00570-z · Cited by 30
Effects of a HIIT Protocol on Cardiovascular Risk Factors in a Type 1 Diabetes Mellitus Population
Alarcón-Gómez, J., Calatayud, J., Chulvi‐Medrano, I., & Martin-Rivera, F. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031262 · Cited by 29
“This would be useful to determine whether insulin sensitivity is modified as reduced insulin exogenous administration is related to a decreased risk of cardiovascular complications in people with T1DM [30,53].”
BackgroundMao, Y., & Zhong, W. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109211 · Cited by 29
The Role of Epigenetics in Arterial Calcification
Wu, S., Lin, X., Yuan, L., & Liao, E.-Y. (2015) · BioMed Research International · doi:10.1155/2015/320849 · Cited by 28
“[4] I.”
BackgroundThe role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes
Chan, C. L., Pyle, L. L., Morehead, R., Baumgartner, A., Cree‐Green, M., & Nadeau, K. J. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12422 · Cited by 25
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
Resnick, O., Bril, F., & Beauchamp, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1520313 · Cited by 25
Cardiovascular Function/Dysfunction in Adolescents with Type 1 Diabetes
Nadeau, K. J., & Reusch, J. E. B. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0180-4 · Cited by 24
Tommerdahl, K. L., Baumgartner, K. V., Schäfer, M., Bjornstad, P., Melena, I. L., Hegemann, S., Baumgartner, A., Pyle, L., Cree‐Green, M., Truong, U. T., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1879 · Cited by 23
Bjornstad, P., Pyle, L. L., Kinney, G. L., Rewers, M., Johnson, R. J., Maahs, D. M., & Snell‐Bergeon, J. K. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.012 · Cited by 22
“Cohort and methods The CACTI Study enrolled subjects 19–56 years old, with and without type 1 diabetes, who were asymptomatic for cardiovascular disease (CVD) at the baseline visit in 2000–2002 and then were re-examined 6 years later, as previously described (Schauer et al., 2011).”
MethodSelf-citation
Metadata
- Authors
- Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M.
- Affiliations
- University of Colorado Anschutz (US)
- Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado Denver, Aurora, Colorado.
- Corresponding author
- Schauer, Irene E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 60
- Issue
- 1
- Pages
- 306-314
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012187
- OpenAlex
- W2140420590
- Cited by
- 230
- References
- 50
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 11 · 2021: 23 · 2020: 13 · 2019: 15 · 2018: 11 · 2017: 19 · 2016: 9 · 2015: 24 · 2014: 17 · 2013: 13 · 2012: 17
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (BIRCWH K12 Program, P30 DK)
- National Heart, Lung, and Blood Institute (R01HL113029, HL61753, R01HL61753, R01HL061753, R01HL079611)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516)
- National Center for Research Resources (M01RR000051)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin resistance, type 1 diabetes, coronary artery calcification, free fatty acids, peripheral glucose utilization, hyperinsulinemic-euglycemic clamp, cardiovascular risk, glycemic control, HbA1c, continuous glucose monitoring, atherosclerosis, diabetic cardiomyopathy, dyslipidemia, dyslipoproteinemia
- MeSH terms
- Abdomen, Adipose Tissue, Adult, Blood Glucose, Body Composition, Calcium, Coronary Vessels, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Environmental Monitoring, Fatty Acids, Fatty Acids, Nonesterified, Female, Glycerol, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Reference Values, Spleen, Tomography, X-Ray Computed, Glucose Clamp Technique, Cohort Studies, Absorptiometry, Photon, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.